RELX does not make headlines the way a chip foundry or an AI lab does, which is rather the point of the business. It sells data, analytics, and the dull certainty of recurring revenue, and it returns the proceeds to shareholders on a metronome. The latest beat of that metronome arrived this week.
The company said it will conduct a new £100m share buyback in July, the next instalment of the roughly £2.25bn it intends to deploy on repurchases across 2026.
The stated purpose is the conventional one: to reduce the company's capital, with the shares bought back held in treasury. The programme is executed by independent financial institutions under the usual UK and EU market-abuse rules, which keep the company at arm's length from the trading itself.
The July tranche follows a steady run of earlier buybacks through the year, including a £200m programme that ran in the first half of June. None of these is, on its own, a market event.
Taken together they are the financial expression of how RELX sees itself: a cash-generative business with more capital than it needs to fund growth, returning the surplus rather than hoarding it.
That posture is easier to hold when the underlying business is performing, and RELX's has been. The group spans scientific publishing through Elsevier, legal data through LexisNexis, risk and analytics, and its exhibitions arm, and the parts that sell proprietary data into professional workflows have proved both durable and, lately, well positioned for the AI cycle.
Owning large, structured, hard-to-replicate datasets is a useful place to stand when every software company is suddenly desperate for exactly that.
It has not been entirely smooth. RELX posted its steepest single-day share decline since 1988 after Anthropic moved its Claude assistant into legal contract review, a reaction some analysts judged overdone given that the proprietary case-law archives held by LexisNexis and its rivals remain a genuine competitive moat.
LexisNexis subsequently folded Anthropic's legal capabilities into its own Protégé AI suite, the response of an incumbent choosing to absorb the new tool rather than fight it.
That episode is the backdrop against which the buybacks should be read. A company returning £2.25bn to shareholders in a single year is signalling confidence that its core, the data nobody else has, holds its value even as generative AI reshapes the software sitting on top of it. The repurchases are a vote, in cash, that the moat is intact.
For shareholders the immediate effect is mechanical. Buying back stock shrinks the share count, which lifts earnings per share and, all else equal, supports the price. It is a less glamorous use of capital than a big acquisition, and a more reliable one. RELX has long preferred the reliable kind.
The July programme will run its course over the month under the same independent execution as the rest. There is no drama in it, and that is the message. RELX is a company whose news is the absence of surprises, and a £100m buyback in July is exactly the sort of non-event it likes to report.